nodes	percent_of_prediction	percent_of_DWPC	metapath
Pergolide—DRD4—obesity	0.0834	0.221	CbGaD
Pergolide—HTR1B—obesity	0.0741	0.197	CbGaD
Pergolide—DRD1—obesity	0.0706	0.187	CbGaD
Pergolide—HTR2C—obesity	0.0604	0.16	CbGaD
Pergolide—DRD2—obesity	0.0498	0.132	CbGaD
Pergolide—ADRA1B—Phendimetrazine—obesity	0.0449	0.119	CbGbCtD
Pergolide—DRD1—Phenylpropanolamine—obesity	0.0405	0.108	CbGbCtD
Pergolide—HTR2A—obesity	0.0385	0.102	CbGaD
Pergolide—ADRA1A—Phendimetrazine—obesity	0.0355	0.0942	CbGbCtD
Pergolide—ADRA2C—Methamphetamine—obesity	0.034	0.0902	CbGbCtD
Pergolide—ADRA2B—Methamphetamine—obesity	0.0322	0.0856	CbGbCtD
Pergolide—ADRA2A—Benzphetamine—obesity	0.028	0.0745	CbGbCtD
Pergolide—ADRA1A—Benzphetamine—obesity	0.0269	0.0714	CbGbCtD
Pergolide—ADRA2A—Phenylpropanolamine—obesity	0.0267	0.071	CbGbCtD
Pergolide—ADRA1A—Phenylpropanolamine—obesity	0.0256	0.0681	CbGbCtD
Pergolide—ADRA2A—Methamphetamine—obesity	0.0224	0.0595	CbGbCtD
Pergolide—CYP2D6—Phentermine—obesity	0.00932	0.0248	CbGbCtD
Pergolide—CYP2D6—Bupropion—obesity	0.00793	0.0211	CbGbCtD
Pergolide—CYP3A4—Sibutramine—obesity	0.00782	0.0208	CbGbCtD
Pergolide—CYP2D6—Methamphetamine—obesity	0.00745	0.0198	CbGbCtD
Pergolide—CYP3A4—Benzphetamine—obesity	0.00593	0.0157	CbGbCtD
Pergolide—CYP2D6—Cimetidine—obesity	0.00582	0.0155	CbGbCtD
Pergolide—CYP3A4—Bupropion—obesity	0.00504	0.0134	CbGbCtD
Pergolide—CYP3A4—Orlistat—obesity	0.00411	0.0109	CbGbCtD
Pergolide—CYP3A4—Cimetidine—obesity	0.0037	0.00983	CbGbCtD
Pergolide—CYP3A4—Topiramate—obesity	0.00242	0.00643	CbGbCtD
Pergolide—HTR2A—sympathetic nervous system—obesity	0.00105	0.0787	CbGeAlD
Pergolide—HTR2A—vagus nerve—obesity	0.00102	0.0762	CbGeAlD
Pergolide—HTR2A—autonomic nervous system—obesity	0.000706	0.0529	CbGeAlD
Pergolide—HTR1A—hindbrain—obesity	0.000499	0.0374	CbGeAlD
Pergolide—ADRA1A—hindbrain—obesity	0.00046	0.0345	CbGeAlD
Pergolide—DRD2—hindbrain—obesity	0.000451	0.0338	CbGeAlD
Pergolide—DRD5—endocrine gland—obesity	0.000321	0.024	CbGeAlD
Pergolide—HTR2A—hindbrain—obesity	0.000298	0.0223	CbGeAlD
Pergolide—Cabergoline—DRD4—obesity	0.000295	0.0808	CrCbGaD
Pergolide—HTR1B—cardiovascular system—obesity	0.000289	0.0217	CbGeAlD
Pergolide—KCNH2—islet of Langerhans—obesity	0.000287	0.0215	CbGeAlD
Pergolide—HTR2B—adrenal cortex—obesity	0.000286	0.0214	CbGeAlD
Pergolide—HTR1D—cardiovascular system—obesity	0.00028	0.021	CbGeAlD
Pergolide—DRD2—respiratory system—obesity	0.000275	0.0206	CbGeAlD
Pergolide—CYP2D6—hindbrain—obesity	0.000271	0.0203	CbGeAlD
Pergolide—Cabergoline—HTR1B—obesity	0.000262	0.0717	CrCbGaD
Pergolide—HTR2B—cardiovascular system—obesity	0.000261	0.0195	CbGeAlD
Pergolide—ADRA1D—endocrine gland—obesity	0.000257	0.0192	CbGeAlD
Pergolide—Cabergoline—DRD1—obesity	0.00025	0.0684	CrCbGaD
Pergolide—Methylergometrine—DRD1—obesity	0.00025	0.0684	CrCbGaD
Pergolide—Ergonovine—HTR2C—obesity	0.000245	0.0669	CrCbGaD
Pergolide—HTR1A—cardiovascular system—obesity	0.000234	0.0175	CbGeAlD
Pergolide—Cabergoline—ADRB1—obesity	0.000232	0.0635	CrCbGaD
Pergolide—HTR2B—adipose tissue—obesity	0.00023	0.0172	CbGeAlD
Pergolide—ADRA2A—islet of Langerhans—obesity	0.000226	0.0169	CbGeAlD
Pergolide—ADRA2C—adrenal cortex—obesity	0.000225	0.0168	CbGeAlD
Pergolide—HTR2B—digestive system—obesity	0.000216	0.0162	CbGeAlD
Pergolide—ADRA1A—cardiovascular system—obesity	0.000215	0.0161	CbGeAlD
Pergolide—Methylergometrine—HTR2C—obesity	0.000214	0.0585	CrCbGaD
Pergolide—Cabergoline—HTR2C—obesity	0.000214	0.0585	CrCbGaD
Pergolide—KCNH2—cardiovascular system—obesity	0.000208	0.0156	CbGeAlD
Pergolide—HTR2B—adrenal gland—obesity	0.000206	0.0154	CbGeAlD
Pergolide—HTR1B—endocrine gland—obesity	0.000198	0.0149	CbGeAlD
Pergolide—Lisuride—DRD4—obesity	0.000198	0.0542	CrCbGaD
Pergolide—Cabergoline—ADRB2—obesity	0.000195	0.0534	CrCbGaD
Pergolide—ADRA1A—adipose tissue—obesity	0.00019	0.0142	CbGeAlD
Pergolide—DRD2—pituitary gland—obesity	0.000187	0.014	CbGeAlD
Pergolide—HTR1A—adrenal gland—obesity	0.000185	0.0138	CbGeAlD
Pergolide—KCNH2—pituitary gland—obesity	0.000184	0.0138	CbGeAlD
Pergolide—HTR2A—respiratory system—obesity	0.000182	0.0136	CbGeAlD
Pergolide—ADRA2C—pituitary gland—obesity	0.000182	0.0136	CbGeAlD
Pergolide—ADRA2C—adipose tissue—obesity	0.000181	0.0135	CbGeAlD
Pergolide—Cabergoline—DRD2—obesity	0.000176	0.0482	CrCbGaD
Pergolide—Lisuride—HTR1B—obesity	0.000176	0.0481	CrCbGaD
Pergolide—ADRA1A—adrenal gland—obesity	0.00017	0.0127	CbGeAlD
Pergolide—Lisuride—DRD1—obesity	0.000168	0.0459	CrCbGaD
Pergolide—KCNH2—adrenal gland—obesity	0.000164	0.0123	CbGeAlD
Pergolide—ADRA2C—adrenal gland—obesity	0.000162	0.0121	CbGeAlD
Pergolide—HTR1A—endocrine gland—obesity	0.00016	0.012	CbGeAlD
Pergolide—Lisuride—ADRB1—obesity	0.000156	0.0426	CrCbGaD
Pergolide—ADRA1A—endocrine gland—obesity	0.000148	0.0111	CbGeAlD
Pergolide—ADRA2A—pituitary gland—obesity	0.000145	0.0108	CbGeAlD
Pergolide—DRD2—endocrine gland—obesity	0.000145	0.0108	CbGeAlD
Pergolide—ADRA2A—adipose tissue—obesity	0.000144	0.0108	CbGeAlD
Pergolide—Lisuride—HTR2C—obesity	0.000144	0.0392	CrCbGaD
Pergolide—KCNH2—endocrine gland—obesity	0.000143	0.0107	CbGeAlD
Pergolide—HTR2A—cardiovascular system—obesity	0.000139	0.0104	CbGeAlD
Pergolide—Cabergoline—HTR2A—obesity	0.000136	0.0372	CrCbGaD
Pergolide—Methylergometrine—HTR2A—obesity	0.000136	0.0372	CrCbGaD
Pergolide—ADRA1A—liver—obesity	0.000133	0.00997	CbGeAlD
Pergolide—ADRA2A—adrenal gland—obesity	0.000129	0.00969	CbGeAlD
Pergolide—ADRA2C—liver—obesity	0.000127	0.0095	CbGeAlD
Pergolide—HTR2A—pituitary gland—obesity	0.000123	0.00923	CbGeAlD
Pergolide—Lisuride—DRD2—obesity	0.000118	0.0323	CrCbGaD
Pergolide—HTR2A—digestive system—obesity	0.000116	0.00865	CbGeAlD
Pergolide—ADRA2A—endocrine gland—obesity	0.000112	0.00841	CbGeAlD
Pergolide—HTR2A—adrenal gland—obesity	0.00011	0.00824	CbGeAlD
Pergolide—CYP3A4—digestive system—obesity	0.000107	0.00801	CbGeAlD
Pergolide—CYP2D6—digestive system—obesity	0.000105	0.00788	CbGeAlD
Pergolide—HTR2A—endocrine gland—obesity	9.55e-05	0.00715	CbGeAlD
Pergolide—Lisuride—HTR2A—obesity	9.14e-05	0.025	CrCbGaD
Pergolide—CYP3A4—endocrine gland—obesity	8.84e-05	0.00662	CbGeAlD
Pergolide—CYP2D6—endocrine gland—obesity	8.7e-05	0.00651	CbGeAlD
Pergolide—HTR2A—liver—obesity	8.61e-05	0.00644	CbGeAlD
Pergolide—Ill-defined disorder—Orlistat—obesity	8.02e-05	0.000641	CcSEcCtD
Pergolide—Headache—Cimetidine—obesity	8e-05	0.00064	CcSEcCtD
Pergolide—Purpura—Topiramate—obesity	8e-05	0.00064	CcSEcCtD
Pergolide—Nausea—Diethylpropion—obesity	7.97e-05	0.000637	CcSEcCtD
Pergolide—CYP3A4—liver—obesity	7.97e-05	0.00597	CbGeAlD
Pergolide—Hypoglycaemia—Topiramate—obesity	7.9e-05	0.000632	CcSEcCtD
Pergolide—CYP2D6—liver—obesity	7.84e-05	0.00587	CbGeAlD
Pergolide—Tremor—Sibutramine—obesity	7.83e-05	0.000626	CcSEcCtD
Pergolide—Eye disorder—Bupropion—obesity	7.83e-05	0.000626	CcSEcCtD
Pergolide—Tinnitus—Bupropion—obesity	7.81e-05	0.000624	CcSEcCtD
Pergolide—Malaise—Orlistat—obesity	7.79e-05	0.000623	CcSEcCtD
Pergolide—Vertigo—Orlistat—obesity	7.76e-05	0.000621	CcSEcCtD
Pergolide—Ill-defined disorder—Sibutramine—obesity	7.76e-05	0.00062	CcSEcCtD
Pergolide—Anaemia—Sibutramine—obesity	7.73e-05	0.000618	CcSEcCtD
Pergolide—Diplopia—Topiramate—obesity	7.71e-05	0.000617	CcSEcCtD
Pergolide—Agitation—Sibutramine—obesity	7.68e-05	0.000614	CcSEcCtD
Pergolide—Disturbance in sexual arousal—Topiramate—obesity	7.65e-05	0.000612	CcSEcCtD
Pergolide—Palpitations—Orlistat—obesity	7.63e-05	0.00061	CcSEcCtD
Pergolide—Migraine—Topiramate—obesity	7.59e-05	0.000607	CcSEcCtD
Pergolide—Affect lability—Topiramate—obesity	7.59e-05	0.000607	CcSEcCtD
Pergolide—Nausea—Cimetidine—obesity	7.59e-05	0.000607	CcSEcCtD
Pergolide—Malaise—Sibutramine—obesity	7.54e-05	0.000603	CcSEcCtD
Pergolide—Cough—Orlistat—obesity	7.54e-05	0.000603	CcSEcCtD
Pergolide—Psychotic disorder—Topiramate—obesity	7.53e-05	0.000602	CcSEcCtD
Pergolide—Chills—Bupropion—obesity	7.51e-05	0.000601	CcSEcCtD
Pergolide—Vertigo—Sibutramine—obesity	7.51e-05	0.000601	CcSEcCtD
Pergolide—Syncope—Sibutramine—obesity	7.5e-05	0.0006	CcSEcCtD
Pergolide—Convulsion—Orlistat—obesity	7.49e-05	0.000599	CcSEcCtD
Pergolide—Leukopenia—Sibutramine—obesity	7.48e-05	0.000598	CcSEcCtD
Pergolide—Arrhythmia—Bupropion—obesity	7.48e-05	0.000598	CcSEcCtD
Pergolide—Face oedema—Topiramate—obesity	7.44e-05	0.000595	CcSEcCtD
Pergolide—Alopecia—Bupropion—obesity	7.4e-05	0.000592	CcSEcCtD
Pergolide—Palpitations—Sibutramine—obesity	7.39e-05	0.000591	CcSEcCtD
Pergolide—Chest pain—Orlistat—obesity	7.36e-05	0.000588	CcSEcCtD
Pergolide—Myalgia—Orlistat—obesity	7.36e-05	0.000588	CcSEcCtD
Pergolide—Loss of consciousness—Sibutramine—obesity	7.35e-05	0.000588	CcSEcCtD
Pergolide—Urinary retention—Topiramate—obesity	7.33e-05	0.000586	CcSEcCtD
Pergolide—Anxiety—Orlistat—obesity	7.33e-05	0.000586	CcSEcCtD
Pergolide—Mood swings—Topiramate—obesity	7.31e-05	0.000584	CcSEcCtD
Pergolide—Cough—Sibutramine—obesity	7.3e-05	0.000583	CcSEcCtD
Pergolide—Discomfort—Orlistat—obesity	7.27e-05	0.000581	CcSEcCtD
Pergolide—Ataxia—Topiramate—obesity	7.25e-05	0.00058	CcSEcCtD
Pergolide—Convulsion—Sibutramine—obesity	7.24e-05	0.000579	CcSEcCtD
Pergolide—Hypertension—Sibutramine—obesity	7.22e-05	0.000577	CcSEcCtD
Pergolide—Dry mouth—Orlistat—obesity	7.19e-05	0.000575	CcSEcCtD
Pergolide—Flatulence—Bupropion—obesity	7.18e-05	0.000574	CcSEcCtD
Pergolide—Dehydration—Topiramate—obesity	7.17e-05	0.000573	CcSEcCtD
Pergolide—Tension—Bupropion—obesity	7.15e-05	0.000572	CcSEcCtD
Pergolide—Dysgeusia—Bupropion—obesity	7.14e-05	0.000571	CcSEcCtD
Pergolide—Liver function test abnormal—Topiramate—obesity	7.12e-05	0.000569	CcSEcCtD
Pergolide—Chest pain—Sibutramine—obesity	7.12e-05	0.000569	CcSEcCtD
Pergolide—Arthralgia—Sibutramine—obesity	7.12e-05	0.000569	CcSEcCtD
Pergolide—Myalgia—Sibutramine—obesity	7.12e-05	0.000569	CcSEcCtD
Pergolide—Anxiety—Sibutramine—obesity	7.09e-05	0.000567	CcSEcCtD
Pergolide—Nervousness—Bupropion—obesity	7.08e-05	0.000566	CcSEcCtD
Pergolide—Oedema—Orlistat—obesity	7.05e-05	0.000564	CcSEcCtD
Pergolide—Back pain—Bupropion—obesity	7.05e-05	0.000564	CcSEcCtD
Pergolide—Orthostatic hypotension—Topiramate—obesity	7.04e-05	0.000563	CcSEcCtD
Pergolide—Discomfort—Sibutramine—obesity	7.03e-05	0.000562	CcSEcCtD
Pergolide—Hypokalaemia—Topiramate—obesity	7.02e-05	0.000561	CcSEcCtD
Pergolide—Infection—Orlistat—obesity	7.01e-05	0.00056	CcSEcCtD
Pergolide—Dry mouth—Sibutramine—obesity	6.96e-05	0.000557	CcSEcCtD
Pergolide—Confusional state—Sibutramine—obesity	6.88e-05	0.00055	CcSEcCtD
Pergolide—Tremor—Bupropion—obesity	6.83e-05	0.000546	CcSEcCtD
Pergolide—Gastritis—Topiramate—obesity	6.82e-05	0.000546	CcSEcCtD
Pergolide—Oedema—Sibutramine—obesity	6.82e-05	0.000546	CcSEcCtD
Pergolide—Hyperhidrosis—Orlistat—obesity	6.82e-05	0.000545	CcSEcCtD
Pergolide—Infection—Sibutramine—obesity	6.78e-05	0.000542	CcSEcCtD
Pergolide—Ill-defined disorder—Bupropion—obesity	6.76e-05	0.000541	CcSEcCtD
Pergolide—Anaemia—Bupropion—obesity	6.74e-05	0.000539	CcSEcCtD
Pergolide—Shock—Sibutramine—obesity	6.71e-05	0.000537	CcSEcCtD
Pergolide—Abdominal distension—Topiramate—obesity	6.71e-05	0.000536	CcSEcCtD
Pergolide—Agitation—Bupropion—obesity	6.7e-05	0.000536	CcSEcCtD
Pergolide—Thrombocytopenia—Sibutramine—obesity	6.68e-05	0.000534	CcSEcCtD
Pergolide—Asthma—Topiramate—obesity	6.67e-05	0.000533	CcSEcCtD
Pergolide—Dysphagia—Topiramate—obesity	6.67e-05	0.000533	CcSEcCtD
Pergolide—Tachycardia—Sibutramine—obesity	6.66e-05	0.000532	CcSEcCtD
Pergolide—Eosinophilia—Topiramate—obesity	6.6e-05	0.000528	CcSEcCtD
Pergolide—Hyperhidrosis—Sibutramine—obesity	6.6e-05	0.000527	CcSEcCtD
Pergolide—Malaise—Bupropion—obesity	6.57e-05	0.000526	CcSEcCtD
Pergolide—Vertigo—Bupropion—obesity	6.55e-05	0.000524	CcSEcCtD
Pergolide—Syncope—Bupropion—obesity	6.54e-05	0.000523	CcSEcCtD
Pergolide—Pancreatitis—Topiramate—obesity	6.53e-05	0.000522	CcSEcCtD
Pergolide—Leukopenia—Bupropion—obesity	6.52e-05	0.000522	CcSEcCtD
Pergolide—Anorexia—Sibutramine—obesity	6.5e-05	0.00052	CcSEcCtD
Pergolide—Angina pectoris—Topiramate—obesity	6.49e-05	0.000519	CcSEcCtD
Pergolide—Palpitations—Bupropion—obesity	6.44e-05	0.000515	CcSEcCtD
Pergolide—Musculoskeletal discomfort—Orlistat—obesity	6.42e-05	0.000514	CcSEcCtD
Pergolide—Bronchitis—Topiramate—obesity	6.41e-05	0.000512	CcSEcCtD
Pergolide—Loss of consciousness—Bupropion—obesity	6.41e-05	0.000512	CcSEcCtD
Pergolide—Insomnia—Orlistat—obesity	6.38e-05	0.00051	CcSEcCtD
Pergolide—Hypotension—Sibutramine—obesity	6.38e-05	0.00051	CcSEcCtD
Pergolide—Cough—Bupropion—obesity	6.36e-05	0.000509	CcSEcCtD
Pergolide—Paraesthesia—Orlistat—obesity	6.33e-05	0.000506	CcSEcCtD
Pergolide—Convulsion—Bupropion—obesity	6.32e-05	0.000505	CcSEcCtD
Pergolide—Hypertension—Bupropion—obesity	6.29e-05	0.000503	CcSEcCtD
Pergolide—Dysuria—Topiramate—obesity	6.23e-05	0.000498	CcSEcCtD
Pergolide—Musculoskeletal discomfort—Sibutramine—obesity	6.22e-05	0.000497	CcSEcCtD
Pergolide—Dyspepsia—Orlistat—obesity	6.21e-05	0.000496	CcSEcCtD
Pergolide—Arthralgia—Bupropion—obesity	6.21e-05	0.000496	CcSEcCtD
Pergolide—Chest pain—Bupropion—obesity	6.21e-05	0.000496	CcSEcCtD
Pergolide—Myalgia—Bupropion—obesity	6.21e-05	0.000496	CcSEcCtD
Pergolide—Anxiety—Bupropion—obesity	6.18e-05	0.000494	CcSEcCtD
Pergolide—Insomnia—Sibutramine—obesity	6.17e-05	0.000493	CcSEcCtD
Pergolide—Pollakiuria—Topiramate—obesity	6.16e-05	0.000492	CcSEcCtD
Pergolide—Erectile dysfunction—Topiramate—obesity	6.14e-05	0.000491	CcSEcCtD
Pergolide—Discomfort—Bupropion—obesity	6.13e-05	0.00049	CcSEcCtD
Pergolide—Decreased appetite—Orlistat—obesity	6.13e-05	0.00049	CcSEcCtD
Pergolide—Paraesthesia—Sibutramine—obesity	6.13e-05	0.00049	CcSEcCtD
Pergolide—Dyspnoea—Sibutramine—obesity	6.08e-05	0.000486	CcSEcCtD
Pergolide—Dry mouth—Bupropion—obesity	6.07e-05	0.000485	CcSEcCtD
Pergolide—Somnolence—Sibutramine—obesity	6.07e-05	0.000485	CcSEcCtD
Pergolide—Weight increased—Topiramate—obesity	6.07e-05	0.000485	CcSEcCtD
Pergolide—Weight decreased—Topiramate—obesity	6.03e-05	0.000482	CcSEcCtD
Pergolide—Pain—Orlistat—obesity	6.03e-05	0.000482	CcSEcCtD
Pergolide—Hyperglycaemia—Topiramate—obesity	6.01e-05	0.000481	CcSEcCtD
Pergolide—Dyspepsia—Sibutramine—obesity	6.01e-05	0.00048	CcSEcCtD
Pergolide—Confusional state—Bupropion—obesity	6e-05	0.00048	CcSEcCtD
Pergolide—Pneumonia—Topiramate—obesity	5.98e-05	0.000478	CcSEcCtD
Pergolide—Oedema—Bupropion—obesity	5.95e-05	0.000476	CcSEcCtD
Pergolide—Decreased appetite—Sibutramine—obesity	5.93e-05	0.000474	CcSEcCtD
Pergolide—Depression—Topiramate—obesity	5.93e-05	0.000474	CcSEcCtD
Pergolide—Infection—Bupropion—obesity	5.91e-05	0.000473	CcSEcCtD
Pergolide—Shock—Bupropion—obesity	5.85e-05	0.000468	CcSEcCtD
Pergolide—Renal failure—Topiramate—obesity	5.84e-05	0.000467	CcSEcCtD
Pergolide—Pain—Sibutramine—obesity	5.84e-05	0.000467	CcSEcCtD
Pergolide—Constipation—Sibutramine—obesity	5.84e-05	0.000467	CcSEcCtD
Pergolide—Neuropathy peripheral—Topiramate—obesity	5.83e-05	0.000466	CcSEcCtD
Pergolide—Thrombocytopenia—Bupropion—obesity	5.82e-05	0.000466	CcSEcCtD
Pergolide—Feeling abnormal—Orlistat—obesity	5.81e-05	0.000465	CcSEcCtD
Pergolide—Tachycardia—Bupropion—obesity	5.81e-05	0.000464	CcSEcCtD
Pergolide—Urinary tract infection—Topiramate—obesity	5.78e-05	0.000462	CcSEcCtD
Pergolide—Conjunctivitis—Topiramate—obesity	5.78e-05	0.000462	CcSEcCtD
Pergolide—Gastrointestinal pain—Orlistat—obesity	5.77e-05	0.000461	CcSEcCtD
Pergolide—Hyperhidrosis—Bupropion—obesity	5.75e-05	0.00046	CcSEcCtD
Pergolide—Anorexia—Bupropion—obesity	5.67e-05	0.000453	CcSEcCtD
Pergolide—Haematuria—Topiramate—obesity	5.67e-05	0.000453	CcSEcCtD
Pergolide—Feeling abnormal—Sibutramine—obesity	5.62e-05	0.00045	CcSEcCtD
Pergolide—Epistaxis—Topiramate—obesity	5.61e-05	0.000448	CcSEcCtD
Pergolide—Gastrointestinal pain—Sibutramine—obesity	5.58e-05	0.000446	CcSEcCtD
Pergolide—Sinusitis—Topiramate—obesity	5.58e-05	0.000446	CcSEcCtD
Pergolide—Abdominal pain—Orlistat—obesity	5.57e-05	0.000446	CcSEcCtD
Pergolide—Body temperature increased—Orlistat—obesity	5.57e-05	0.000446	CcSEcCtD
Pergolide—Hypotension—Bupropion—obesity	5.56e-05	0.000444	CcSEcCtD
Pergolide—Bradycardia—Topiramate—obesity	5.43e-05	0.000434	CcSEcCtD
Pergolide—Musculoskeletal discomfort—Bupropion—obesity	5.42e-05	0.000433	CcSEcCtD
Pergolide—Body temperature increased—Sibutramine—obesity	5.39e-05	0.000431	CcSEcCtD
Pergolide—Abdominal pain—Sibutramine—obesity	5.39e-05	0.000431	CcSEcCtD
Pergolide—Insomnia—Bupropion—obesity	5.38e-05	0.00043	CcSEcCtD
Pergolide—Rhinitis—Topiramate—obesity	5.35e-05	0.000428	CcSEcCtD
Pergolide—Paraesthesia—Bupropion—obesity	5.34e-05	0.000427	CcSEcCtD
Pergolide—Hepatitis—Topiramate—obesity	5.33e-05	0.000427	CcSEcCtD
Pergolide—Hallucination—Topiramate—obesity	5.31e-05	0.000424	CcSEcCtD
Pergolide—Dyspnoea—Bupropion—obesity	5.3e-05	0.000424	CcSEcCtD
Pergolide—Pharyngitis—Topiramate—obesity	5.29e-05	0.000423	CcSEcCtD
Pergolide—Somnolence—Bupropion—obesity	5.29e-05	0.000423	CcSEcCtD
Pergolide—Oedema peripheral—Topiramate—obesity	5.26e-05	0.00042	CcSEcCtD
Pergolide—Dyspepsia—Bupropion—obesity	5.24e-05	0.000419	CcSEcCtD
Pergolide—Decreased appetite—Bupropion—obesity	5.17e-05	0.000413	CcSEcCtD
Pergolide—Visual impairment—Topiramate—obesity	5.14e-05	0.000411	CcSEcCtD
Pergolide—Constipation—Bupropion—obesity	5.09e-05	0.000407	CcSEcCtD
Pergolide—Pain—Bupropion—obesity	5.09e-05	0.000407	CcSEcCtD
Pergolide—Asthenia—Orlistat—obesity	5.06e-05	0.000404	CcSEcCtD
Pergolide—Pruritus—Orlistat—obesity	4.99e-05	0.000399	CcSEcCtD
Pergolide—Eye disorder—Topiramate—obesity	4.99e-05	0.000399	CcSEcCtD
Pergolide—Tinnitus—Topiramate—obesity	4.97e-05	0.000398	CcSEcCtD
Pergolide—Feeling abnormal—Bupropion—obesity	4.9e-05	0.000392	CcSEcCtD
Pergolide—Asthenia—Sibutramine—obesity	4.9e-05	0.000391	CcSEcCtD
Pergolide—Gastrointestinal pain—Bupropion—obesity	4.86e-05	0.000389	CcSEcCtD
Pergolide—Pruritus—Sibutramine—obesity	4.83e-05	0.000386	CcSEcCtD
Pergolide—Diarrhoea—Orlistat—obesity	4.82e-05	0.000386	CcSEcCtD
Pergolide—Chills—Topiramate—obesity	4.79e-05	0.000383	CcSEcCtD
Pergolide—Alopecia—Topiramate—obesity	4.71e-05	0.000377	CcSEcCtD
Pergolide—Body temperature increased—Bupropion—obesity	4.7e-05	0.000376	CcSEcCtD
Pergolide—Abdominal pain—Bupropion—obesity	4.7e-05	0.000376	CcSEcCtD
Pergolide—Diarrhoea—Sibutramine—obesity	4.67e-05	0.000373	CcSEcCtD
Pergolide—Dizziness—Orlistat—obesity	4.66e-05	0.000373	CcSEcCtD
Pergolide—Flatulence—Topiramate—obesity	4.58e-05	0.000366	CcSEcCtD
Pergolide—Tension—Topiramate—obesity	4.56e-05	0.000364	CcSEcCtD
Pergolide—Dysgeusia—Topiramate—obesity	4.55e-05	0.000364	CcSEcCtD
Pergolide—Dizziness—Sibutramine—obesity	4.51e-05	0.000361	CcSEcCtD
Pergolide—Nervousness—Topiramate—obesity	4.51e-05	0.000361	CcSEcCtD
Pergolide—Back pain—Topiramate—obesity	4.49e-05	0.000359	CcSEcCtD
Pergolide—Vomiting—Orlistat—obesity	4.48e-05	0.000358	CcSEcCtD
Pergolide—Rash—Orlistat—obesity	4.45e-05	0.000355	CcSEcCtD
Pergolide—Dermatitis—Orlistat—obesity	4.44e-05	0.000355	CcSEcCtD
Pergolide—Headache—Orlistat—obesity	4.42e-05	0.000353	CcSEcCtD
Pergolide—Tremor—Topiramate—obesity	4.35e-05	0.000348	CcSEcCtD
Pergolide—Vomiting—Sibutramine—obesity	4.34e-05	0.000347	CcSEcCtD
Pergolide—Ill-defined disorder—Topiramate—obesity	4.31e-05	0.000345	CcSEcCtD
Pergolide—Rash—Sibutramine—obesity	4.3e-05	0.000344	CcSEcCtD
Pergolide—Dermatitis—Sibutramine—obesity	4.3e-05	0.000344	CcSEcCtD
Pergolide—Anaemia—Topiramate—obesity	4.29e-05	0.000343	CcSEcCtD
Pergolide—Headache—Sibutramine—obesity	4.28e-05	0.000342	CcSEcCtD
Pergolide—Asthenia—Bupropion—obesity	4.27e-05	0.000341	CcSEcCtD
Pergolide—Agitation—Topiramate—obesity	4.27e-05	0.000341	CcSEcCtD
Pergolide—Pruritus—Bupropion—obesity	4.21e-05	0.000337	CcSEcCtD
Pergolide—Nausea—Orlistat—obesity	4.19e-05	0.000335	CcSEcCtD
Pergolide—Malaise—Topiramate—obesity	4.19e-05	0.000335	CcSEcCtD
Pergolide—Vertigo—Topiramate—obesity	4.17e-05	0.000334	CcSEcCtD
Pergolide—Syncope—Topiramate—obesity	4.16e-05	0.000333	CcSEcCtD
Pergolide—Leukopenia—Topiramate—obesity	4.16e-05	0.000332	CcSEcCtD
Pergolide—Palpitations—Topiramate—obesity	4.1e-05	0.000328	CcSEcCtD
Pergolide—Loss of consciousness—Topiramate—obesity	4.08e-05	0.000326	CcSEcCtD
Pergolide—Diarrhoea—Bupropion—obesity	4.07e-05	0.000325	CcSEcCtD
Pergolide—Nausea—Sibutramine—obesity	4.05e-05	0.000324	CcSEcCtD
Pergolide—Cough—Topiramate—obesity	4.05e-05	0.000324	CcSEcCtD
Pergolide—Convulsion—Topiramate—obesity	4.02e-05	0.000322	CcSEcCtD
Pergolide—Hypertension—Topiramate—obesity	4.01e-05	0.000321	CcSEcCtD
Pergolide—Arthralgia—Topiramate—obesity	3.95e-05	0.000316	CcSEcCtD
Pergolide—Myalgia—Topiramate—obesity	3.95e-05	0.000316	CcSEcCtD
Pergolide—Chest pain—Topiramate—obesity	3.95e-05	0.000316	CcSEcCtD
Pergolide—Anxiety—Topiramate—obesity	3.94e-05	0.000315	CcSEcCtD
Pergolide—Dizziness—Bupropion—obesity	3.93e-05	0.000315	CcSEcCtD
Pergolide—Discomfort—Topiramate—obesity	3.91e-05	0.000312	CcSEcCtD
Pergolide—Dry mouth—Topiramate—obesity	3.87e-05	0.000309	CcSEcCtD
Pergolide—Confusional state—Topiramate—obesity	3.82e-05	0.000306	CcSEcCtD
Pergolide—Oedema—Topiramate—obesity	3.79e-05	0.000303	CcSEcCtD
Pergolide—Vomiting—Bupropion—obesity	3.78e-05	0.000302	CcSEcCtD
Pergolide—Infection—Topiramate—obesity	3.77e-05	0.000301	CcSEcCtD
Pergolide—Rash—Bupropion—obesity	3.75e-05	0.0003	CcSEcCtD
Pergolide—Dermatitis—Bupropion—obesity	3.75e-05	0.0003	CcSEcCtD
Pergolide—Shock—Topiramate—obesity	3.73e-05	0.000298	CcSEcCtD
Pergolide—Headache—Bupropion—obesity	3.73e-05	0.000298	CcSEcCtD
Pergolide—Thrombocytopenia—Topiramate—obesity	3.71e-05	0.000297	CcSEcCtD
Pergolide—Tachycardia—Topiramate—obesity	3.7e-05	0.000296	CcSEcCtD
Pergolide—Hyperhidrosis—Topiramate—obesity	3.66e-05	0.000293	CcSEcCtD
Pergolide—Anorexia—Topiramate—obesity	3.61e-05	0.000289	CcSEcCtD
Pergolide—Hypotension—Topiramate—obesity	3.54e-05	0.000283	CcSEcCtD
Pergolide—Nausea—Bupropion—obesity	3.53e-05	0.000283	CcSEcCtD
Pergolide—Musculoskeletal discomfort—Topiramate—obesity	3.45e-05	0.000276	CcSEcCtD
Pergolide—Insomnia—Topiramate—obesity	3.43e-05	0.000274	CcSEcCtD
Pergolide—Paraesthesia—Topiramate—obesity	3.4e-05	0.000272	CcSEcCtD
Pergolide—Dyspnoea—Topiramate—obesity	3.38e-05	0.00027	CcSEcCtD
Pergolide—Somnolence—Topiramate—obesity	3.37e-05	0.000269	CcSEcCtD
Pergolide—Dyspepsia—Topiramate—obesity	3.34e-05	0.000267	CcSEcCtD
Pergolide—Decreased appetite—Topiramate—obesity	3.29e-05	0.000263	CcSEcCtD
Pergolide—Pain—Topiramate—obesity	3.24e-05	0.000259	CcSEcCtD
Pergolide—Constipation—Topiramate—obesity	3.24e-05	0.000259	CcSEcCtD
Pergolide—Feeling abnormal—Topiramate—obesity	3.12e-05	0.00025	CcSEcCtD
Pergolide—Gastrointestinal pain—Topiramate—obesity	3.1e-05	0.000248	CcSEcCtD
Pergolide—Abdominal pain—Topiramate—obesity	3e-05	0.00024	CcSEcCtD
Pergolide—Body temperature increased—Topiramate—obesity	3e-05	0.00024	CcSEcCtD
Pergolide—Asthenia—Topiramate—obesity	2.72e-05	0.000217	CcSEcCtD
Pergolide—Pruritus—Topiramate—obesity	2.68e-05	0.000214	CcSEcCtD
Pergolide—Diarrhoea—Topiramate—obesity	2.59e-05	0.000207	CcSEcCtD
Pergolide—Dizziness—Topiramate—obesity	2.51e-05	0.0002	CcSEcCtD
Pergolide—Vomiting—Topiramate—obesity	2.41e-05	0.000193	CcSEcCtD
Pergolide—Rash—Topiramate—obesity	2.39e-05	0.000191	CcSEcCtD
Pergolide—Dermatitis—Topiramate—obesity	2.39e-05	0.000191	CcSEcCtD
Pergolide—Headache—Topiramate—obesity	2.37e-05	0.00019	CcSEcCtD
Pergolide—Nausea—Topiramate—obesity	2.25e-05	0.00018	CcSEcCtD
Pergolide—ADRA2A—Signaling Pathways—POMC—obesity	9.33e-07	8.9e-06	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—INS—obesity	9.28e-07	8.85e-06	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—PIK3CD—obesity	9.27e-07	8.85e-06	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—MAPK8—obesity	9.27e-07	8.84e-06	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—MAPK8—obesity	9.27e-07	8.84e-06	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—TYK2—obesity	9.26e-07	8.83e-06	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—MTOR—obesity	9.25e-07	8.82e-06	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—PIK3CB—obesity	9.25e-07	8.82e-06	CbGpPWpGaD
Pergolide—ADRA1D—Signaling by GPCR—AKT1—obesity	9.24e-07	8.82e-06	CbGpPWpGaD
Pergolide—DRD3—Signaling by GPCR—AKT1—obesity	9.24e-07	8.82e-06	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—FASN—obesity	9.24e-07	8.81e-06	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—MYC—obesity	9.2e-07	8.77e-06	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—BCHE—obesity	9.2e-07	8.77e-06	CbGpPWpGaD
Pergolide—ADRA2B—GPCR downstream signaling—AKT1—obesity	9.19e-07	8.76e-06	CbGpPWpGaD
Pergolide—ADRA1A—GPCR downstream signaling—PIK3CA—obesity	9.19e-07	8.76e-06	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—RHOA—obesity	9.18e-07	8.76e-06	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—TGFB1—obesity	9.18e-07	8.75e-06	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—SERPINE1—obesity	9.17e-07	8.75e-06	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—CCL2—obesity	9.13e-07	8.71e-06	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—TYK2—obesity	9.11e-07	8.69e-06	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—STAT3—obesity	9.11e-07	8.69e-06	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—MTOR—obesity	9.1e-07	8.68e-06	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—PIK3CB—obesity	9.1e-07	8.68e-06	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—MTHFR—obesity	9.09e-07	8.67e-06	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—NOS3—obesity	9.09e-07	8.67e-06	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—PIK3R1—obesity	9.09e-07	8.67e-06	CbGpPWpGaD
Pergolide—ADRA2B—Signaling by GPCR—IL6—obesity	9.05e-07	8.63e-06	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—RHOA—obesity	9.04e-07	8.62e-06	CbGpPWpGaD
Pergolide—DRD5—Signaling Pathways—IL6—obesity	9.03e-07	8.61e-06	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—MYC—obesity	9.01e-07	8.59e-06	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—TGFB1—obesity	8.99e-07	8.57e-06	CbGpPWpGaD
Pergolide—ADRA2A—Metabolism—PIK3CB—obesity	8.98e-07	8.57e-06	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—IGF1—obesity	8.97e-07	8.56e-06	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—AKT2—obesity	8.97e-07	8.55e-06	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—NOS3—obesity	8.94e-07	8.53e-06	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—PIK3R1—obesity	8.94e-07	8.53e-06	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—TYK2—obesity	8.92e-07	8.51e-06	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—PPARA—obesity	8.92e-07	8.51e-06	CbGpPWpGaD
Pergolide—ADRA2A—Metabolism—PTGS2—obesity	8.9e-07	8.49e-06	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—CYP2E1—obesity	8.87e-07	8.46e-06	CbGpPWpGaD
Pergolide—HTR1A—GPCR downstream signaling—AKT1—obesity	8.87e-07	8.46e-06	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—MYC—obesity	8.86e-07	8.45e-06	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—RHOA—obesity	8.85e-07	8.44e-06	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—TGFB1—obesity	8.84e-07	8.43e-06	CbGpPWpGaD
Pergolide—HTR2C—GPCR downstream signaling—AKT1—obesity	8.83e-07	8.42e-06	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—NQO1—obesity	8.78e-07	8.37e-06	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—PIK3R1—obesity	8.76e-07	8.35e-06	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—NOS3—obesity	8.76e-07	8.35e-06	CbGpPWpGaD
Pergolide—HTR1A—Signaling by GPCR—IL6—obesity	8.73e-07	8.33e-06	CbGpPWpGaD
Pergolide—HTR2C—Signaling by GPCR—IL6—obesity	8.69e-07	8.29e-06	CbGpPWpGaD
Pergolide—DRD2—Signaling by GPCR—PIK3CA—obesity	8.66e-07	8.26e-06	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—AGT—obesity	8.64e-07	8.24e-06	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—PIK3CD—obesity	8.62e-07	8.22e-06	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—MMP9—obesity	8.6e-07	8.21e-06	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—STAT3—obesity	8.59e-07	8.19e-06	CbGpPWpGaD
Pergolide—ADRA2C—GPCR downstream signaling—AKT1—obesity	8.58e-07	8.19e-06	CbGpPWpGaD
Pergolide—ADRA2A—GPCR downstream signaling—PIK3CA—obesity	8.53e-07	8.14e-06	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—SERPINE1—obesity	8.52e-07	8.13e-06	CbGpPWpGaD
Pergolide—HTR2A—Signaling by GPCR—PIK3CA—obesity	8.52e-07	8.13e-06	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—STAT3—obesity	8.47e-07	8.08e-06	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—STAT3—obesity	8.47e-07	8.08e-06	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—APOE—obesity	8.46e-07	8.07e-06	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—MYC—obesity	8.46e-07	8.07e-06	CbGpPWpGaD
Pergolide—ADRA2C—Signaling by GPCR—IL6—obesity	8.45e-07	8.06e-06	CbGpPWpGaD
Pergolide—ADRA1B—GPCR downstream signaling—AKT1—obesity	8.45e-07	8.06e-06	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—TGFB1—obesity	8.44e-07	8.05e-06	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—GCG—obesity	8.41e-07	8.02e-06	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—SLC2A4—obesity	8.41e-07	8.02e-06	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—PIK3CB—obesity	8.39e-07	8e-06	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—MTOR—obesity	8.39e-07	8e-06	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—CAV1—obesity	8.39e-07	8e-06	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—MAPK8—obesity	8.37e-07	7.98e-06	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—APOA1—obesity	8.37e-07	7.98e-06	CbGpPWpGaD
Pergolide—ADRA2B—Signaling by GPCR—AKT1—obesity	8.34e-07	7.96e-06	CbGpPWpGaD
Pergolide—ADRA1A—Signaling by GPCR—PIK3CA—obesity	8.34e-07	7.96e-06	CbGpPWpGaD
Pergolide—DRD5—Signaling Pathways—AKT1—obesity	8.33e-07	7.94e-06	CbGpPWpGaD
Pergolide—ADRA1B—Signaling by GPCR—IL6—obesity	8.32e-07	7.93e-06	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—MMP9—obesity	8.31e-07	7.92e-06	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—CYCS—obesity	8.3e-07	7.92e-06	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—TYK2—obesity	8.29e-07	7.91e-06	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—MMP9—obesity	8.26e-07	7.88e-06	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—MTOR—obesity	8.26e-07	7.87e-06	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—PIK3CB—obesity	8.26e-07	7.87e-06	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—RHOA—obesity	8.22e-07	7.84e-06	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—GGT1—obesity	8.15e-07	7.77e-06	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—GOT1—obesity	8.15e-07	7.77e-06	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—PIK3R1—obesity	8.14e-07	7.76e-06	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—NOS3—obesity	8.14e-07	7.76e-06	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—MTOR—obesity	8.08e-07	7.71e-06	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—PIK3CB—obesity	8.08e-07	7.71e-06	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—MAPK8—obesity	8.08e-07	7.7e-06	CbGpPWpGaD
Pergolide—HTR1A—Signaling by GPCR—AKT1—obesity	8.06e-07	7.68e-06	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—MMP9—obesity	8.04e-07	7.67e-06	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—MAPK8—obesity	8.04e-07	7.66e-06	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—NCOA1—obesity	8.03e-07	7.65e-06	CbGpPWpGaD
Pergolide—HTR2C—Signaling by GPCR—AKT1—obesity	8.01e-07	7.64e-06	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—MYC—obesity	7.98e-07	7.61e-06	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—TGFB1—obesity	7.96e-07	7.59e-06	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—MMP9—obesity	7.91e-07	7.54e-06	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—STK11—obesity	7.91e-07	7.54e-06	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—CYP19A1—obesity	7.91e-07	7.54e-06	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—MYC—obesity	7.87e-07	7.51e-06	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—MYC—obesity	7.87e-07	7.51e-06	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—TGFB1—obesity	7.85e-07	7.49e-06	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—TGFB1—obesity	7.85e-07	7.49e-06	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—MAPK8—obesity	7.82e-07	7.46e-06	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—PIK3CA—obesity	7.81e-07	7.45e-06	CbGpPWpGaD
Pergolide—ADRA2C—Signaling by GPCR—AKT1—obesity	7.8e-07	7.43e-06	CbGpPWpGaD
Pergolide—DRD2—GPCR downstream signaling—AKT1—obesity	7.79e-07	7.43e-06	CbGpPWpGaD
Pergolide—ADRA2A—Signaling by GPCR—PIK3CA—obesity	7.75e-07	7.39e-06	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—MAPK8—obesity	7.69e-07	7.34e-06	CbGpPWpGaD
Pergolide—ADRA1B—Signaling by GPCR—AKT1—obesity	7.67e-07	7.32e-06	CbGpPWpGaD
Pergolide—DRD2—Signaling by GPCR—IL6—obesity	7.67e-07	7.31e-06	CbGpPWpGaD
Pergolide—HTR2A—GPCR downstream signaling—AKT1—obesity	7.66e-07	7.31e-06	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—STAT3—obesity	7.65e-07	7.3e-06	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—PIK3CA—obesity	7.65e-07	7.29e-06	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—PIK3CG—obesity	7.64e-07	7.29e-06	CbGpPWpGaD
Pergolide—HTR2A—Signaling by GPCR—IL6—obesity	7.54e-07	7.2e-06	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—PIK3CA—obesity	7.52e-07	7.18e-06	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—MTOR—obesity	7.51e-07	7.16e-06	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—PIK3CB—obesity	7.51e-07	7.16e-06	CbGpPWpGaD
Pergolide—ADRA1A—GPCR downstream signaling—AKT1—obesity	7.5e-07	7.16e-06	CbGpPWpGaD
Pergolide—ADRA1A—Signaling by GPCR—IL6—obesity	7.39e-07	7.05e-06	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—STAT3—obesity	7.38e-07	7.04e-06	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—PPARG—obesity	7.37e-07	7.03e-06	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—COMT—obesity	7.35e-07	7.01e-06	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—STAT3—obesity	7.35e-07	7.01e-06	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—MMP9—obesity	7.29e-07	6.96e-06	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—POMC—obesity	7.27e-07	6.93e-06	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—GNB3—obesity	7.25e-07	6.92e-06	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—PPARGC1A—obesity	7.25e-07	6.92e-06	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—INS—obesity	7.23e-07	6.9e-06	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—HMOX1—obesity	7.22e-07	6.88e-06	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—PIK3CA—obesity	7.18e-07	6.85e-06	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—MMP9—obesity	7.18e-07	6.84e-06	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—STAT3—obesity	7.15e-07	6.82e-06	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—MYC—obesity	7.11e-07	6.78e-06	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—MAPK8—obesity	7.09e-07	6.76e-06	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—TGFB1—obesity	7.09e-07	6.76e-06	CbGpPWpGaD
Pergolide—DRD2—Signaling by GPCR—AKT1—obesity	7.07e-07	6.75e-06	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—GNAS—obesity	7.06e-07	6.73e-06	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—STAT3—obesity	7.03e-07	6.71e-06	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—MMP9—obesity	7.03e-07	6.7e-06	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—MAPK8—obesity	6.98e-07	6.66e-06	CbGpPWpGaD
Pergolide—ADRA2A—GPCR downstream signaling—AKT1—obesity	6.97e-07	6.65e-06	CbGpPWpGaD
Pergolide—HTR2A—Signaling by GPCR—AKT1—obesity	6.96e-07	6.64e-06	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—IL6—obesity	6.92e-07	6.6e-06	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—APOB—obesity	6.91e-07	6.59e-06	CbGpPWpGaD
Pergolide—ADRA2A—Signaling by GPCR—IL6—obesity	6.86e-07	6.55e-06	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—MYC—obesity	6.86e-07	6.55e-06	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—TGFB1—obesity	6.85e-07	6.53e-06	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—MAPK8—obesity	6.83e-07	6.52e-06	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—MYC—obesity	6.83e-07	6.51e-06	CbGpPWpGaD
Pergolide—ADRA1A—Signaling by GPCR—AKT1—obesity	6.81e-07	6.5e-06	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—TGFB1—obesity	6.81e-07	6.5e-06	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—PIK3CA—obesity	6.77e-07	6.46e-06	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—IL6—obesity	6.77e-07	6.46e-06	CbGpPWpGaD
Pergolide—ADRA2C—Metabolism—PIK3CA—obesity	6.74e-07	6.43e-06	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—PIK3CD—obesity	6.71e-07	6.4e-06	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—PIK3CA—obesity	6.68e-07	6.38e-06	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—PIK3CA—obesity	6.68e-07	6.38e-06	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—IL6—obesity	6.66e-07	6.36e-06	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—MYC—obesity	6.64e-07	6.33e-06	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—ALB—obesity	6.63e-07	6.32e-06	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—TGFB1—obesity	6.62e-07	6.32e-06	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—LPL—obesity	6.6e-07	6.3e-06	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—MYC—obesity	6.54e-07	6.23e-06	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—MMP9—obesity	6.53e-07	6.23e-06	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—TGFB1—obesity	6.52e-07	6.22e-06	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—STAT3—obesity	6.48e-07	6.18e-06	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—GPX1—obesity	6.44e-07	6.14e-06	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—AKT1—obesity	6.38e-07	6.09e-06	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—STAT3—obesity	6.38e-07	6.09e-06	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—IL6—obesity	6.36e-07	6.07e-06	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—MAPK8—obesity	6.35e-07	6.06e-06	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—NOS3—obesity	6.34e-07	6.05e-06	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—PIK3R1—obesity	6.34e-07	6.05e-06	CbGpPWpGaD
Pergolide—ADRA2A—Signaling by GPCR—AKT1—obesity	6.33e-07	6.04e-06	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—CD36—obesity	6.27e-07	5.98e-06	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—AKT1—obesity	6.25e-07	5.96e-06	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—STAT3—obesity	6.25e-07	5.96e-06	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—AKT1—obesity	6.15e-07	5.86e-06	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—PIK3CA—obesity	6.03e-07	5.76e-06	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—MYC—obesity	6.02e-07	5.75e-06	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—TGFB1—obesity	6.01e-07	5.73e-06	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—IL6—obesity	6e-07	5.72e-06	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—MTHFR—obesity	5.94e-07	5.67e-06	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—MYC—obesity	5.93e-07	5.65e-06	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—IL6—obesity	5.92e-07	5.65e-06	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—IL6—obesity	5.92e-07	5.65e-06	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—TGFB1—obesity	5.91e-07	5.64e-06	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—AKT1—obesity	5.87e-07	5.6e-06	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—PIK3CB—obesity	5.85e-07	5.58e-06	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—PPARA—obesity	5.83e-07	5.56e-06	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—PIK3CA—obesity	5.83e-07	5.56e-06	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—MYC—obesity	5.8e-07	5.54e-06	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—STAT3—obesity	5.8e-07	5.54e-06	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—PTGS2—obesity	5.8e-07	5.53e-06	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—PIK3CA—obesity	5.8e-07	5.53e-06	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—TGFB1—obesity	5.79e-07	5.52e-06	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—AGT—obesity	5.65e-07	5.39e-06	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—PIK3CA—obesity	5.64e-07	5.38e-06	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—PIK3CA—obesity	5.55e-07	5.29e-06	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—AKT1—obesity	5.53e-07	5.28e-06	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—APOE—obesity	5.53e-07	5.28e-06	CbGpPWpGaD
Pergolide—ADRA2C—Metabolism—AKT1—obesity	5.51e-07	5.25e-06	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—CAV1—obesity	5.48e-07	5.23e-06	CbGpPWpGaD
Pergolide—ADRA2A—Metabolism—PIK3CA—obesity	5.48e-07	5.22e-06	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—APOA1—obesity	5.47e-07	5.22e-06	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—AKT1—obesity	5.46e-07	5.21e-06	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—AKT1—obesity	5.46e-07	5.21e-06	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—MYC—obesity	5.39e-07	5.14e-06	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—TGFB1—obesity	5.38e-07	5.13e-06	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—IL6—obesity	5.34e-07	5.1e-06	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—IL6—obesity	5.16e-07	4.92e-06	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—IL6—obesity	5.13e-07	4.89e-06	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—PIK3CA—obesity	5.11e-07	4.88e-06	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—PIK3CA—obesity	5.03e-07	4.8e-06	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—PIK3CG—obesity	4.99e-07	4.76e-06	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—IL6—obesity	4.99e-07	4.76e-06	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—AKT1—obesity	4.93e-07	4.7e-06	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—PIK3CA—obesity	4.93e-07	4.7e-06	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—IL6—obesity	4.91e-07	4.69e-06	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—PPARG—obesity	4.82e-07	4.6e-06	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—AKT1—obesity	4.76e-07	4.54e-06	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—POMC—obesity	4.75e-07	4.53e-06	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—AKT1—obesity	4.73e-07	4.52e-06	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—INS—obesity	4.73e-07	4.51e-06	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—AKT1—obesity	4.6e-07	4.39e-06	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—PIK3CA—obesity	4.58e-07	4.37e-06	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—AKT1—obesity	4.53e-07	4.32e-06	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—IL6—obesity	4.53e-07	4.32e-06	CbGpPWpGaD
Pergolide—ADRA2A—Metabolism—AKT1—obesity	4.47e-07	4.27e-06	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—IL6—obesity	4.46e-07	4.25e-06	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—PIK3CD—obesity	4.39e-07	4.19e-06	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—IL6—obesity	4.36e-07	4.16e-06	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—ALB—obesity	4.33e-07	4.13e-06	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—AKT1—obesity	4.18e-07	3.99e-06	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—NOS3—obesity	4.15e-07	3.95e-06	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—PIK3R1—obesity	4.15e-07	3.95e-06	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—AKT1—obesity	4.11e-07	3.92e-06	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—IL6—obesity	4.05e-07	3.87e-06	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—AKT1—obesity	4.03e-07	3.84e-06	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—PIK3CB—obesity	3.83e-07	3.65e-06	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—PTGS2—obesity	3.79e-07	3.62e-06	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—AKT1—obesity	3.74e-07	3.57e-06	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—PIK3CA—obesity	3.57e-07	3.4e-06	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—AKT1—obesity	2.91e-07	2.78e-06	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—PIK3CA—obesity	2.33e-07	2.22e-06	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—AKT1—obesity	1.91e-07	1.82e-06	CbGpPWpGaD
